339.93USD-0.58%Mkt Cap: 9.34B USDP/E: —Last update: 2026-06-01
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance i…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap9.34B USD
Enterprise Value8.97B USD
Revenue (TTM)—
Gross Profit-284.30M USD
Net Income (TTM)-303.27M USD
Revenue/Share—
Last Price339.93 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees168
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-35.53
PEG—
EV/EBITDA-25.12
EV/Revenue—
P/S—
P/B6.92
EPS (TTM)-13.39
EPS (Forward)-9.85
52W Range
36.3092% of range366.52
52W High366.52 USD
52W Low36.30 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-34.54%
ROA-32.33%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-249.07M USD
CapEx (TTM)56.00K USD
FCF Margin—
FCF Yield-1.88%
Net Debt-785.43M USD
Net Debt/EBITDA2.20
Balance Sheet
Debt/Equity0.00
Current Ratio15.88
Quick Ratio15.66
Book Value/Sh50.61 USD
Cash/Share28.23 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateNov 29, 2023
Analyst Consensus
Rating1.5 (Strong Buy)
Target (Mean)652.18 USD
Target Range166.00 USD – 1245.00 USD
# Analysts17
Ownership
Shares Out.27.88M
Float24.01M
Insiders0.32%
Institutions115.80%
Short Interest
Short Ratio9.0d
Short % Float13.33%
Short % Out.13.30%
Shares Short3.71M
Short (prev mo.)3.78M
Technical
SMA 50326.64 (+4.1%)
SMA 200229.96 (+47.8%)
Beta2.78
S&P 52W Chg27.70%
Avg Vol (30d)346.80K
Avg Vol (10d)309.06K
Technical Indicators
RSI (14)52.3
MACD5.7690
MACD Signal4.9802
MACD Hist.+0.7889
BB Upper359.92 USD
BB Middle339.01 USD
BB Lower318.11 USD
BB Width12.33%
ATR (14)18.87 USD
Vol Ratio (20d)0.48x